Hello. Please sign in!

Recommendations on Standards for the Design of Medical Diagnostic Equipment for Adults with Disabilities, Advisory Committee Final Report

APPENDIX B

Presentation given by Bob Menke, Midmark Corporation, at the February 27, 2013 Advisory Committee Meeting:

Two slides from a presentation given by Midmark to the MDE Advisory Committee. One is the introductory slide with the title of the presentation, ""Examination Table Accessibility Standards", who it was being presented to and the date. The second slide gives an overview of the presentation.
Two slides from a presentation given by Midmark to the MDE Advisory Committee. One is the introductory slide with the title of the presentation, ""Examination Table Accessibility Standards", who it was being presented to and the date. The second slide gives an overview of the presentation.
Third and fourth slides from Midmark's presentation. Slide three gives information about Bob Menke the Midmark representative and presenter. Slide four shows two current examination table/chair designs that are currently available. A woman in a wheelchair is positioned between the two tables.
Third and fourth slides from Midmark's presentation. Slide three gives information about Bob Menke the Midmark representative and presenter. Slide four shows two current examination table/chair designs that are currently available. A woman in a wheelchair is positioned between the two tables.
Slide 5 contains information on the methodology used in determining the height of current examination tables. Slide 6 contains the table height from the proposed MDE Standard.
Slide 5 contains information on the methodology used in determining the height of current examination tables. Slide 6 contains the table height from the proposed MDE Standard.
Slide 7 contains the existing height requirements from the ADA/ABA Accessibility Guidelines. Slide 8 contains a graph depicting the types of examination tables sold between 2005 and 2012. The y axis indicates the percent of tables sold that are adjustable height (blue) and fixed height (red). The x axis indicates the quarter and year of the data (e.g., first quarter in 2005, extreme left).
Slide 7 contains the existing height requirements from the ADA/ABA Accessibility Guidelines. Slide 8 contains a graph depicting the types of examination tables sold between 2005 and 2012. The y axis indicates the percent of tables sold that are adjustable height (blue) and fixed height (red). The x axis indicates the quarter and year of the data (e.g., first quarter in 2005, extreme left).
Slide 9 contains a graph showing sales percentages of fixed height versus manual medical tables. Slide 10 contains a graph showing how the health system has been shifting to adjustable height tables.
Slide 9 contains a graph showing sales percentages of fixed height versus manual medical tables. Slide 10 contains a graph showing how the health system has been shifting to adjustable height tables.
Slide 11 shows what the current population of tables. Slide 12 compare what the NPRM proposed to what the committee agreed to for the width of the transfer surface.
Slide 11 shows what the current population of tables. Slide 12 compare what the NPRM proposed to what the committee agreed to for the width of the transfer surface.
Slide 13 shows the weight capacity for current tables. Slide 14 shows the NPRM proposal for the depth of the transfer surface and what the committee agreed to.
Slide 13 shows the weight capacity for current tables. Slide 14 shows the NPRM proposal for the depth of the transfer surface and what the committee agreed to.
Slide 15 shows the NPRM proposal for transfer supports and armrest and what the committee agreed to. Slide 16 gives a summary of the current environment for tables height, transfer width, transfer depth, and armrests.
Slide 15 shows the NPRM proposal for transfer supports and armrest and what the committee agreed to. Slide 16 gives a summary of the current environment for tables height, transfer width, transfer depth, and armrests.
Slide 17: Benefits and Costs. Slide 18: Goals - Maximize percentage of available accessible tables; minimize cost to health care providers.
Slide 17: Benefits and Costs. Slide 18: Goals - Maximize percentage of available accessible tables; minimize cost to health care providers.
Slide 19 contains financial assumptions and slide 20 contains an overview of what contributes to the cost to the provider.
Slide 19 contains financial assumptions and slide 20 contains an overview of what contributes to the cost to the provider.
Slide 21 contains current cost of the equipment and cost with recommended changes. Slide 22 contains cost date for lowering the minimum table height
Slide 21 contains current cost of the equipment and cost with recommended changes. Slide 22 contains cost date for lowering the minimum table height
Slide 23 contains cost increases to add transfer and leg supports. Slide 24 contains possible scoping scenarios for when the Standard is adopted by a standard setting agency.
Slide 23 contains cost increases to add transfer and leg supports. Slide 24 contains possible scoping scenarios for when the Standard is adopted by a standard setting agency.
Slide 25 contains pricing for possible scenarios and slide 26 contains a benefits and cost summary.
Slide 25 contains pricing for possible scenarios and slide 26 contains a benefits and cost summary.
Slide 27 contains additional information on the benefits and costs and slide 28 is a introductory slide for the summary of findings and recommendations.
Slide 27 contains additional information on the benefits and costs and slide 28 is a introductory slide for the summary of findings and recommendations.
Slide 29 contains summary of current environment compared to the committee recommendations for width and depth and showing the low height remaining at 17 to 19. Slide 30 shows a summary of costs and benefits.
Slide 29 contains summary of current environment compared to the committee recommendations for width and depth and showing the low height remaining at 17 to 19. Slide 30 shows a summary of costs and benefits.
Slide 31 contains recommendations and slide 32 states back-up slides.
Slide 31 contains recommendations and slide 32 states back-up slides.
Slide 33 contains weight data and slide 34 contains market projection with baseline scenarios.
Slide 33 contains weight data and slide 34 contains market projection with baseline scenarios.
Both slides contain costs of different scoping scenarios.
Both slides contain costs of different scoping scenarios.
.Both slide contain more scenarios and costs.
Both slide contain more scenarios and costs.
Final two slide show more scoping scenarios and cost projections.
Final two slide show more scoping scenarios and cost projections.

[MORE INFO...]

*You must sign in to view [MORE INFO...]